20 results
Pathogenesis of Diabetic Ketoacidosis - Insulin deficiency or severe insulin insensitivity 

#DKA #Pathophysiology #Endocrinology #Diabetes #Ketoacidosis
Pathogenesis of Diabetic ... insensitivity #DKA #Pathophysiology ... #Endocrinology ... #Diabetes #Ketoacidosis ... #Diabetic
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... of Diabetic Ketoacidosis ... #dka #hhs #pathophysiology ... #comparison #endocrinology ... #diabetes #diabetic
Diabetes Pathophysiology and Medication Targets

The ominous octet is one concept that summarizes the different pathophysiologic pathways
Diabetes Pathophysiology ... hyperglycemia in type 2 diabetes ... commonly used diabetes ... /ambcarerx #Diabetes ... Targets #Drug #Endocrinology
Diabetes Insipidus vs Syndrome of Inappropriate ADH (SIADH) - Comparison Table

Diabetes Insipidus - Inadequate ADH
SIADH -
Diabetes Insipidus ... Comparison Table Diabetes ... Excess ADH #Diabetes ... Comparison #Table #Pathophysiology ... Symptoms #Diagnosis #Endocrinology
Pathophysiology and Effects of Insulin Deficiency

#Insulin #Deficiency #DKA #Ketoacidosis #Diabetes #Pathophysiology #Endocrinology
Pathophysiology ... #Ketoacidosis #Diabetes ... #Pathophysiology ... #Endocrinology
Stages in the Development of Diabetes Type 1

#Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
Development of Diabetes ... Type 1 #Diabetes ... #Development #Pathophysiology ... Timeline #Diagnosis #Endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... #Pathophysiology ... #Diabetic #Ketoacidosis ... #DKA #Diabetes ... #Endocrinology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... sarahthelyon #Diabetes ... #pharmacology #pathophysiology ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes ... comparison #table #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... diagnosis #management #endocrinology